8th Annual Cell Culture & Bioprocessing Congress

Over 350 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

Over 40 presentations, case studies and panel discussions focusing on the key issues in cell line optimisation, 3D cell culture and bioprocessing technologies

4 interactive streams:

Cell Line Development

PART 1: Early Cell Culture & Cell Line Engineering

PART 2: 3D Cell Culture Models & Applications

Process Development: Upstream Bioprocessing and Analytics

Cell Line Development: Late Stage Cell Line Development, Stability, Data & Assay Data Development

Cell Culture and Downstream Bioprocessing

View Agenda: https://bit.ly/2s1Ng0J

For further information about the congress, please contact Guillaume Alonso at g.alonso@oxfordglobal.co.uk or visit the website https://bit.ly/2GF3jGh

Simon Chell , Director, Discovery Biology, AstraZeneca

Rob Howes, Director, Reagents and Assay Development, Discovery Sciences, AstraZeneca

Manuel Carrondo, Vice President, Instituto de Biologia Experimental e Tecnologica

Remben Talaban, Scientific Investigator and GSK Associate Fellow, GlaxoSmithKline

Daniele Perna, Investigator, GlaxoSmithKline